비타민D 관련 휴지기 탈모증

Q: Does 비타민D help with 휴지기 탈모증?

Based on 34 studies with 17,842 participants, there is insufficient evidence at this time that 비타민D may support 휴지기 탈모증 management. Our evidence grade is F (Evidence Against).

Q: How much 비타민D should I take for 휴지기 탈모증?

Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of 비타민D?

Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for 비타민D and 휴지기 탈모증?

We rate the evidence as Grade F (Evidence Against). This rating is based on 34 peer-reviewed studies with 17,842 total participants. The overall direction of effect is mixed.

F 효과 연구에 따르면 이 용도에 효과가 있을 가능성은 낮은 것으로 나타납니다.

총 17,842명의 참여자를 대상으로 한 32건의 연구(메타분석 1건, RCT 1건)에 근거합니다. 연구 결과는 혼재되어 있습니다.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dtelogen\u002Deffluvium'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

결론

Despite frequent associations between low vitamin D and telogen effluvium, research does not clearly support vitamin D supplementation as an effective approach for this type of hair shedding.

Lower vitamin D levels are common in telogen effluvium patients but may not be the cause
No well-designed RCTs demonstrate that supplementation resolves telogen effluvium
Post-COVID hair loss studies show inconsistent findings regarding vitamin D
Correcting a deficiency is reasonable, but vitamin D alone is unlikely to resolve hair shedding

Key Study Findings

retrospective observational n=113

Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.

Dose: None vs: Placebo 효과: None None

narrative review

Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.

Dose: None vs: Placebo 효과: None None

Review

Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients.

Dose: None vs: Placebo 효과: None None

Meta-analysis

Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis.

Dose: None vs: Placebo 효과: OR=2.84 (AA vs controls), OR=5.24 (FPHL vs controls) p<0.01

case-control study n=180

A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, …

Dose: not applicable vs: Placebo 효과: None None

meta_analysis n=10670

Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis.

Dose: not applicable (observational meta-analysis) vs: Placebo 효과: WMD -7.29 ng/mL (95% CI -9.21, -5.38); OR for vitamin D deficiency 3.11 (95% CI 2.29, 4.22) not explicitly stated; CI does

Key Statistics

연구

17842

참여자

↔

Mixed

등급

Referenced Papers

Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients. Review

Nutrients 2025 2 인용

Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases. Other

International journal of … 2025

Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions. Review

Journal of drugs … 2025

A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … Other

Journal of cosmetic … 2024 7 인용

Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis. Meta-Analysis

Journal of cosmetic … 2024 7 인용

Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case … Other

Archives of dermatological … 2024 5 인용

Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis. Systematic Review

Frontiers in nutrition 2024 4 인용

Filling the Gaps: Vitamin D Status in Diffuse Hair Fall Among Pakistanis. Other

Dermatology practical & … 2024

Etiology, management, and outcomes of pediatric telogen effluvium: A single-center study in the United States. Other

Pediatric dermatology 2023 9 인용

Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center. Other

Dermatology practical & … 2023 4 인용

The development of non-scarring alopecia in women who wear the hijab. Other

Archives of dermatological … 2023 3 인용

Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation. Other

International journal of … 2023 1 인용

Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. Other

Journal of cosmetic … 2022 22 인용

The role of micronutrients in the management of COIVD-19 and optimizing vaccine efficacy. Review

Human nutrition & … 2022 9 인용

Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? Other

Turkish journal of … 2022 8 인용

Reply to "Vitamin D status in scarring and nonscarring alopecia". Other

Journal of the … 2022 6 인용

Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients. Other

Dermatology practical & … 2022 6 인용

Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities. Other

JAAD international 2022 6 인용

Telogen Effluvium - a review of the science and current obstacles. Review

Journal of dermatological … 2021 51 인용

Role of vitamin D in hair loss: A short review. Review

Journal of cosmetic … 2021 44 인용

Characteristics of telogen effluvium in COVID-19 in western Iran (2020). Other

Anais brasileiros de … 2021 26 인용

Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review. Review

Cureus 2021 20 인용

Efficacy of Oral Vitamin D3 Therapy in Patients Suffering from Diffuse Hair Loss (Telogen Effluvium). Other

Journal of nutritional … 2021 12 인용

Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review. Review

Dermatology online journal 2021 3 인용

Study of serum vitamin D levels in men with premature androgenetic alopecia. Other

International journal of … 2020 18 인용

Topical L-thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy? Review

Experimental dermatology 2020 10 인용

NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. Observational

Journal of cosmetic … 2019 25 인용

Vitamin D Receptor Gene Polymorphism In Chronic Telogen Effluvium; A Case-Control Study. Other

Clinical, cosmetic and … 2019 7 인용

The Role of Vitamin D in Non-Scarring Alopecia. Review

International journal of … 2017 61 인용

Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study. Other

Journal of drugs … 2016 56 인용

Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. Other

International journal of … 2016 28 인용

Use of Vitamins and Minerals in the Treatment of Hair Loss: A Cross-Sectional Survey among Dermatologists in Saudi Arabia. Other

Journal of cutaneous … 2014 10 인용

Serum ferritin and vitamin d in female hair loss: do they play a role? Other

Skin pharmacology and … 2013 127 인용

'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with … RCT

The British journal … 2005 40 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:: 600-800 IU/day
deficiency:: 1,000-5,000 IU/day

상한량: 4,000 IU/day

연구에서 사용된 용량

용량	기간	효과	N
None	--	Neutral	113
None	--	Positive	--
None	--	Mixed	--
None	--	Negative	--
not applicable	--	Mixed	180
not applicable (observational meta-analysis)	--	Negative	10670
None	--	Mixed	100
None	--	Neutral	120

권장 복용 시간: With a fat-containing meal for optimal absorption

Safety & Side Effects

보고된 부작용

⚠ Hypercalcemia at very high doses (nausea, vomiting, weakness)
⚠ Kidney stones with excessive long-term use
⚠ Constipation
⚠ Metallic taste

알려진 상호작용

● Thiazide diuretics (may increase risk of hypercalcemia)
● Corticosteroids (reduce vitamin D absorption and metabolism)
● Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)

일일 최대 섭취 허용량: 4,000 IU/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 비타민D help with 휴지기 탈모증?

Based on 34 studies with 17,842 participants, there is insufficient evidence at this time that 비타민D may support 휴지기 탈모증 management. Our evidence grade is F (Evidence Against).

How much 비타민D should I take for 휴지기 탈모증?

Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of 비타민D?

Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for 비타민D and 휴지기 탈모증?

We rate the evidence as Grade F (Evidence Against). This rating is based on 34 peer-reviewed studies with 17,842 total participants. The overall direction of effect is mixed.

비타민D 다른 건강 상태에 대한 근거

원형 탈모증 A 여성형 탈모증 A

한눈에 보기

총 17,842명의 참여자를 대상으로 한 32건의 연구(메타분석 1건, RCT 1건)에 근거합니다. 연구 결과는 혼재되어 있습니다.

Evidence Strength10%

Low confidence

연구 분석

RCT (1)Meta (1)Other (32)

대안 비교

이 건강 상태에 대한 다른 성분의 비교 결과를 확인하세요.

모든 성분 보기: 휴지기 탈모증

자세히 알아보기

References

[1] Andrea Sechi et al.. Nutrients. 2025. Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients. doi:10.3390/nu17091451 PubMed
[2] Namrata Chhabra et al.. Int J Trichology. 2025. Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases. doi:10.4103/ijt.ijt_38_22 PubMed
[3] Adam Leavitt et al.. J Drugs Dermatol. 2025. Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions. doi:10.36849/JDD.8763 PubMed
[4] Irem Nur Durusu Turkoglu et al.. J Cosmet Dermatol. 2024. A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid … doi:10.1111/jocd.16512 PubMed
[5] Yuling Chen et al.. J Cosmet Dermatol. 2024. Serum 25 hydroxyvitamin D in non-scarring alopecia: A systematic review and meta-analysis. doi:10.1111/jocd.16093 PubMed
[6] Nermeen Ibrahim Bedair et al.. Arch Dermatol Res. 2024. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case … doi:10.1007/s00403-024-03004-1 PubMed
[7] Tanat Yongpisarn et al.. Front Nutr. 2024. Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis. doi:10.3389/fnut.2024.1479337 PubMed
[8] Palwasha Jalil et al.. Dermatol Pract Concept. 2024. Filling the Gaps: Vitamin D Status in Diffuse Hair Fall Among Pakistanis. doi:10.5826/dpc.1404a232 PubMed
[9] Vivien Chen et al.. Pediatr Dermatol. 2023. Etiology, management, and outcomes of pediatric telogen effluvium: A single-center study in the United States. doi:10.1111/pde.15154 PubMed
[10] Hakan Arslan et al.. Dermatol Pract Concept. 2023. Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center. doi:10.5826/dpc.1303a202 PubMed
[11] Marissa S Ceresnie et al.. Arch Dermatol Res. 2023. The development of non-scarring alopecia in women who wear the hijab. doi:10.1007/s00403-023-02713-3 PubMed
[12] Rania Ahmed El-Tatawy et al.. Int J Trichology. 2023. Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation. doi:10.4103/ijt.ijt_92_22 PubMed
[13] Ahu Yorulmaz et al.. J Cosmet Dermatol. 2022. Telogen effluvium in daily practice: Patient characteristics, laboratory parameters, and treatment modalities of 3028 patients with telogen effluvium. doi:10.1111/jocd.14413 PubMed
[14] Noor Altooq et al.. Hum Nutr Metab. 2022. The role of micronutrients in the management of COIVD-19 and optimizing vaccine efficacy. doi:10.1016/j.hnm.2022.200141 PubMed
[15] Ümran Öner et al.. Turk J Med Sci. 2022. Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom? doi:10.3906/sag-2106-28 PubMed
[16] Shawn Afvari et al.. J Am Acad Dermatol. 2022. Reply to "Vitamin D status in scarring and nonscarring alopecia". doi:10.1016/j.jaad.2022.04.055 PubMed
[17] Saadet İbiş et al.. Dermatol Pract Concept. 2022. Evaluation of MCV/RDW Ratio and Correlations With Ferritin in Telogen Effluvium Patients. doi:10.5826/dpc.1203a151 PubMed
[18] Elizabeth J Klein et al.. JAAD Int. 2022. Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities. doi:10.1016/j.jdin.2022.08.013 PubMed
[19] Ginny Oong Chien Yin et al.. J Dermatol Sci. 2021. Telogen Effluvium - a review of the science and current obstacles. doi:10.1016/j.jdermsci.2021.01.007 PubMed
[20] Kriteeka Saini et al.. J Cosmet Dermatol. 2021. Role of vitamin D in hair loss: A short review. doi:10.1111/jocd.14421 PubMed
[21] Khaled Babaei et al.. An Bras Dermatol. 2021. Characteristics of telogen effluvium in COVID-19 in western Iran (2020). doi:10.1016/j.abd.2021.05.006 PubMed
[22] Zainab Zubair et al.. Cureus. 2021. Prevalence of Low Serum Vitamin D Levels in Patients Presenting With Androgenetic Alopecia: A Review. doi:10.7759/cureus.20431 PubMed
[23] Farah Sattar et al.. J Nutr Sci Vitaminol (Tokyo). 2021. Efficacy of Oral Vitamin D3 Therapy in Patients Suffering from Diffuse Hair Loss (Telogen Effluvium). doi:10.3177/jnsv.67.68 PubMed
[24] Diana Gruenstein et al.. Dermatol Online J. 2021. Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review. doi:10.5070/D3271055619 PubMed
[25] Sarita Sanke et al.. Int J Dermatol. 2020. Study of serum vitamin D levels in men with premature androgenetic alopecia. doi:10.1111/ijd.14982 PubMed
[26] Ralf Paus et al.. Exp Dermatol. 2020. Topical L-thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy? doi:10.1111/exd.14156 PubMed
[27] Kavita Poonia et al.. J Cosmet Dermatol. 2019. NonScarring Diffuse Hair Loss in Women: a Clinico-Etiological Study from tertiary care center in North-West India. doi:10.1111/jocd.12559 PubMed
[28] Iman Seleit et al.. Clin Cosmet Investig Dermatol. 2019. Vitamin D Receptor Gene Polymorphism In Chronic Telogen Effluvium; A Case-Control Study. doi:10.2147/CCID.S227232 PubMed
[29] Agnieszka Gerkowicz et al.. Int J Mol Sci. 2017. The Role of Vitamin D in Non-Scarring Alopecia. doi:10.3390/ijms18122653 PubMed
[30] Evelyn J Cheung et al.. J Drugs Dermatol. 2016. Vitamin and Mineral Deficiencies in Patients With Telogen Effluvium: A Retrospective Cross-Sectional Study. PubMed
[31] Tee Wei Siah et al.. Int J Trichology. 2016. Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center. doi:10.4103/0974-7753.188033 PubMed
[32] Thamer Mubki. J Cutan Med Surg. 2014. Use of Vitamins and Minerals in the Treatment of Hair Loss: A Cross-Sectional Survey among Dermatologists in Saudi Arabia. doi:10.2310/7750.2014.14008 PubMed
[33] H Rasheed et al.. Skin Pharmacol Physiol. 2013. Serum ferritin and vitamin d in female hair loss: do they play a role? doi:10.1159/000346698 PubMed
[34] T O Bleiker et al.. Br J Dermatol. 2005. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with … doi:10.1111/j.1365-2133.2005.06608.x PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.

비타민D 관련 휴지기 탈모증

Embed This Widget

결론

Key Study Findings

Key Statistics

Referenced Papers

Dosage & Usage

일반적으로 사용되는 용량

연구에서 사용된 용량

Safety & Side Effects

보고된 부작용

알려진 상호작용

Frequently Asked Questions

Related Evidence

관련 다른 성분: 휴지기 탈모증

비타민D 다른 건강 상태에 대한 근거

References